Total sample (n = 21) | Insulin (n = 12) | Non-insulin (n = 9) | |
---|---|---|---|
Number of hypoglycaemic episodes, n (%) | |||
1 | 11 (52) | 7 (58) | 4 (44) |
2–3 | 8 (38) | 4 (33) | 4 (44) |
4–5 | 2 (10) | 1 (8) | 1 (11) |
Glucose level assessed during hypoglycaemia, n (%) | |||
Level 1 3.0–3.8 mmol/l | 16 (76) | 9 (75) | 7 (78) |
Level 2 < 3.0 mmol/l | 5 (24) | 4 (33) | 1 (11) |
Duration of hypoglycaemia (h), median (range) | 1.25 (0.15–8.50) | 1.45 (0.15–8.50) | 0.36 (0.25–6.0) |
HbA1c (mmol/mol), median (range)a | 52 (38–80) | 58 (48–80) | 42 (38–48) |
HbA1c (%), median (range)a | 6.9 (5.6–9.5) | 7.5 (6.5–9.5) | 6.0 (5.6–6.5) |
eGFR (ml/min/1.73 m2), median (range)a | 61 (22–110) | 58 (22–101) | 66 (40–110) |
Weight (kg), median (range)a | 75 (63–96) | 72 (63–96) | 77 (64–92) |
Body mass index (kg/m2), median (range)a | 24 (21–39) | 28 (22–39) | 24 (21–32) |
Glucose variability (CV), median%(range) | 28.8 (14.2; 39.4) | 31.8 (20.3; 39.4) | 24.2 (14.2; 39.1) |